NYSE: ANVS
Annovis Bio Inc Stock Ownership - Who owns Annovis Bio?

Insider buying vs selling

Have Annovis Bio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael B. HoffmanDirector2025-12-0830,000$4.34
$130.20kBuy
Michael B. HoffmanDirector2025-12-0815,000$4.24
$63.60kBuy
Michael B. HoffmanDirector2025-11-241,489$4.13
$6.15kBuy
Michael B. HoffmanDirector2025-11-249,200$3.85
$35.42kBuy
Michael B. HoffmanDirector2025-11-241,489$4.13
$6.15kBuy
Michael B. HoffmanDirector2025-11-2428,096$4.15
$116.60kBuy
Michael B. HoffmanDirector2025-11-24415$4.14
$1.72kBuy
Michael B. HoffmanDirector2025-11-249,200$3.85
$35.42kBuy
Michael B. HoffmanDirector2025-11-2428,096$4.15
$116.60kBuy
Michael B. HoffmanDirector2025-11-24415$4.14
$1.72kBuy

1 of 3

ANVS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANVS insiders and whales buy or sell their stock.

ANVS Shareholders

What type of owners hold Annovis Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Michael B. Hoffman9.87%2,798,096$7.67MInsider
Marialuisa MacCecchini4.27%1,212,020$3.32MInsider
Vanguard Group Inc3.26%923,201$2.53MInstitution
Marshall Wace LLP2.56%725,862$1.99MInstitution
Two Sigma Investments LP1.95%551,837$1.51MInstitution
Susquehanna International Group LLP1.07%303,287$831.01kInstitution
Jane Street Group LLC0.89%251,157$688.17kInstitution
Geode Capital Management LLC0.78%222,132$608.64kInstitution
Da Davidson Co0.57%160,779$440.53kInstitution
Blackrock Inc0.49%139,533$382.32kInstitution

1 of 3

ANVS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANVS14.95%14.97%Net Buying
GANX22.32%3.61%
MNOV10.68%88.78%
GRCE27.97%45.52%
XBIT7.53%46.67%

Annovis Bio Stock Ownership FAQ

Who owns Annovis Bio?

Annovis Bio (NYSE: ANVS) is owned by 14.95% institutional shareholders, 14.97% Annovis Bio insiders, and 70.08% retail investors. Michael B. Hoffman is the largest individual Annovis Bio shareholder, owning 2.80M shares representing 9.87% of the company. Michael B. Hoffman's Annovis Bio shares are currently valued at $6.91M.

If you're new to stock investing, here's how to buy Annovis Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.